INFORMED.
LIVE

SOLARA ACTIVE PHARMA SCIENCES LIMITED

BSE: SOLARA541540ISIN INE624Z01016
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹740.80+0.10 (+0.01%)
as of 18 Sep 2026
SOLARA ACTIVE PHARMA SCIENCES LIMITED share price, 18 Sep 2025 to 18 Sep 2026: ₹685.90 to ₹740.80 (+8.0%). Low ₹432.65, high ₹749.05. Volume shown below the price.
52W high
₹774.00
52W low
₹422.85
Off 52W high
-4.29%
1M return
+34.72%
3M return
+31.58%
6M return
+64.97%
1Y return
+8.00%
20D avg volume
34,753
50 DMA
₹588.03
200 DMA
₹539.24

Key ratios Consolidated

Market cap
₹3,561 Cr
Current price
₹740.80
52W high / low
₹774.00 / ₹422.85
Face value
₹10.00
P/E
-2,206.21
P/B
EPS (TTM)
₹-0.34
Book value / share
ROE
ROCE
6.10%
Operating margin
Net margin
Debt / equity
0.53
Net debt
₹660.06 Cr
Interest cover
0.92
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
128.8 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
381.60387.29349.00313.54319.15273.01
2.694.690.000.490.985.95
367.98383.24359.68324.13309.61281.06
180.81182.23175.71149.69165.14143.67
0.860.772.720.000.005.05
56.0555.4755.2354.8653.6452.29
21.6427.5722.4520.8323.9029.12
26.7126.0425.5724.4923.5824.30
67.1576.7269.8369.9562.0257.26
16.318.74-10.68-10.1010.52-2.10
0.000.86-6.750.000.000.00
16.319.60-17.43-10.1010.52-2.10
0.000.000.000.000.000.00
16.319.60-17.43-10.1010.52-2.10
3.522.20-3.98-2.362.46-0.93
Key metrics
64.6663.2130.5935.2258.0051.32
16.90%16.30%8.80%11.20%18.20%18.80%
4.30%2.50%-5.00%-3.20%3.30%-0.80%
2.60%0.80%2.10%
19.60%41.90%
55.00%557.10%
MetricTTMFY26FY25FY24
Income statement
1,4311,3691,284
7.876.168.32
1,4351,3771,292
688.44672.77581.66
4.353.495.75
221.61219.20211.69
92.4994.75114.81
102.8199.6899.25
283.65278.52239.38
4.27-1.520.54
-5.89-5.890.00
-1.62-7.410.54
0.000.000.00
-1.62-7.410.54
-0.62-1.680.14
Key metrics
193.68187.02214.60
13.53%13.70%16.70%
-0.11%-0.50%0.00%
6.10%9.00%
6.60%
-1,472.20%
100.09172.88
-20.64394.11
0.530.71
660.06772.11
128.8112.6
Balance sheet
2,3332,232
858.10728.73
4.483.95
438.72326.57
317.87317.90
41.6067.77
793.18738.68
273.90248.62
893.91944.11
664.54776.06
554.09662.20
110.45113.86
1,2561,097
Cash flow
152.91212.82
-98.83-36.83
-53.55-180.48
52.8239.94
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
381.60387.29349.00313.54319.15273.01
1.924.420.000.490.985.95
366.53382.84359.67324.11309.60283.84
180.81182.23175.71149.69165.14143.67
0.860.772.720.000.005.05
56.0555.4755.2354.8653.6452.28
20.2327.0622.4520.8323.9029.12
26.7126.0425.5724.4923.5824.30
67.1176.8369.8269.9362.0160.05
16.998.87-10.67-10.0810.53-4.88
0.000.86-6.750.000.000.00
16.999.73-17.42-10.0810.53-4.88
0.000.000.000.000.000.00
16.999.73-17.42-10.0810.53-4.88
3.672.23-3.97-2.362.46-1.65
Key metrics
63.9362.8330.6035.2458.0148.54
16.80%16.20%8.80%11.20%18.20%17.80%
4.50%2.50%-5.00%-3.20%3.30%-1.80%
2.60%0.80%1.90%
19.60%41.90%
61.30%299.40%
MetricTTMFY26FY25FY24
Income statement
1,4311,3691,284
6.835.899.14
1,4331,3761,294
688.44672.77581.66
4.353.495.75
221.61219.20211.68
90.5794.24114.81
102.8199.6899.25
283.69278.59241.83
5.11-1.35-1.08
-5.89-5.890.00
-0.78-7.24-1.08
0.000.000.00
-0.78-7.24-1.08
-0.43-1.64-0.27
Key metrics
192.60186.68212.98
13.46%13.60%16.60%
-0.05%-0.50%-0.10%
6.30%8.80%
6.60%
-570.40%
100.07172.86
-21.12-197.04
0.490.71
611.03772.25
130.5114.3
Balance sheet
2,2772,225
808.69728.60
4.003.81
438.87326.57
317.87317.90
41.5167.78
786.58732.08
267.58242.59
887.53938.07
615.03776.06
554.09662.20
60.94113.86
1,2551,096
Cash flow
152.89212.80
-50.14-36.83
-102.56-180.48
52.8239.94

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
41.92%
HolderTypeHoldingPreviousChange
DEVICAM CAPITAL LLPPromoter Group15.47%
PRONOMZ VENTURES LLPPromoter9.71%
AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITEDPublic3.78%
SPIRACCA VENTURES LLP .Public3.54%
SRJR ENTERPRISE LLPPromoter Group3.52%
ARUN KUMAR PILLAIPromoter3.46%
K R RAVISHANKARPromoter2.75%
THE SCOTTISH ORIENTAL SMALLER COMPANIES TRUSTPLCPublic2.33%
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTDPublic2.17%
CHAYADEEP VENTURES LLPPromoter Group2.10%
FSSA INDIAN SUBCONTINENT FUND AS SUB FUND OF FIRST SENTIER INVESTORS GLOBAL UMBRELLA FUND PLCPublic1.83%
AGNUS CAPITAL LLPPromoter Group1.76%
TPG GROWTH IV SF PTE. LTD.Public1.49%
ROUTE ONE OFFSHORE MASTER FUND, L.P.Public1.44%
RAPTAKOS, BRETT AND CO. LTD.Public1.38%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results